Hims & Hers Stock Crashes: Novo Nordisk Abruptly Ends Collaboration

On Monday morning, Novo Nordisk prohibited Hims & Hers Health from selling the cheaper Wegovy product. However, the explanation for this abrupt decision, which caused Hims' stock price to drop by more than 30%, is not clearly understandable.   The core of the conflict: illegal sale of semaglutide imitations?   Novo stated that Hims violated the law by selling personalized doses of compounded semaglutide, a mimic of Wegovy, " against the law .” This law prohibits the mass sale of compounded semaglutide since the end of May.   ...